1. A Retrospective Validation of International Consortium for MDS/MPN Response Criteria in CMML Treated with Hypomethylating Agents. (April 2017) Authors: Duchmann, M.; Braun, T.; Micol, J.B.; Platzbecker, U.; Park, S.; Pilorge, S.; Beyne-Rauzy, O.; Vey, N.; Sébert, M.; Gruson, B.; Dumas, P.Y.; Guieze, R.; Chretien, M.L.; Laribi, K.; Chait, Y.; Legros, L.; Hirsch, P.; Solary, E.; Fenaux, P.; Itzykson, R. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0161 CLONAL HEMATOPOIESIS IS INCREASED AND NOT RELATED TO AGING IN SYSTEMIC SCLEROSIS. (13th June 2020) Authors: Ricard, L.; Hirsch, P.; Mohty, M.; Fain, O.; Gaugler, B.; Rossignol, J.; Delhommeau, F.; Mekinian, A. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S162: SOMATIC GENETIC LANDSCAPE IN GATA2 DEFICIENCY PATIENTS. (23rd June 2022) Authors: Largeaud, L.; Collin, M.; Monselet, N.; Vergez, F.; Larcher, L.; Hirsch, P.; Duployez, N.; Bustamante, J.; Bellanné-Chantelot, C.; Donadieu, J.; Sicre de Fontbrune, F.; Nolla, M.; Fieschi, C.; Delhommeau, F.; Delabesse, E.; Pasquet, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients. (1st March 2022) Authors: Georgin‐Lavialle, S.; Terrier, B.; Guedon, A.F.; Heiblig, M.; Comont, T.; Lazaro, E.; Lacombe, V.; Terriou, L.; Ardois, S.; Bouaziz, J.‐D.; Mathian, A.; Le Guenno, G.; Aouba, A.; Outh, R.; Meyer, A.; Roux‐Sauvat, M.; Ebbo, M.; Zhao, L.P.; Bigot, A.; Jamilloux, Y. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 50 BCL2L10-POSITIVE CELL (BPC) QUANTIFICATION IS A PREDICTIVE FACTOR OF SURVIVAL IN AZA-TREATED HIGHER RISK MDS (HR-MDS) AND AML. (April 2015) Authors: Cluzeau, T.; Vidal, V.; Ginet, C.; Karsenti, J.M.; Luciano, F.; Gastaud, L.; Garnier, G.; Braun, T.; Hirsch, P.; Raffoux, E.; Nloga, A.M.; Dombret, H.; Rorhlich, P.; Ades, L.; Chomienne, C.; Auberger, P.; Robert, G.; Fenaux, P. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients. (28th November 2021) Authors: Georgin‐Lavialle, S.; Terrier, B.; Guedon, A.F.; Heiblig, M.; Comont, T.; Lazaro, E.; Lacombe, V.; Terriou, L.; Ardois, S.; Bouaziz, J.‐D.; Mathian, A.; Le Guenno, G.; Aouba, A.; Outh, R.; Meyer, A.; Roux‐Sauvat, M.; Ebbo, M.; Zhao, L.P.; Bigot, A.; Jamilloux, Y. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗